The 11th Capital Cell Investment Forum will be held on 24 February, online, presenting the latest rounds of investment active in biotechnology and health in this equity crowdfunding platform. Noteworthy among these rounds: Aortyx (devices for aortic surgery), VB Devices (devices for vascular medicine) and Pharmacelera (computational chemistry services for drug development), which are CataloniaBio & HealthTech members.

Opening Speech by Santiago Munné, co-founder of HOMU Health Ventures.

Interested investors will have the opportunity to hear the start-ups' pitches and hold private meetings with their executive teams.

Since 2015, Capital Cell has closed 43 rounds of funding for more than €53 million, with co-investors that include Alta Life Sciences, Genesis Biomed, Inveready, Ship2B and WA4Steam.

More information